全文获取类型
收费全文 | 5833篇 |
免费 | 344篇 |
国内免费 | 45篇 |
专业分类
耳鼻咽喉 | 69篇 |
儿科学 | 395篇 |
妇产科学 | 81篇 |
基础医学 | 766篇 |
口腔科学 | 127篇 |
临床医学 | 469篇 |
内科学 | 1129篇 |
皮肤病学 | 128篇 |
神经病学 | 312篇 |
特种医学 | 181篇 |
外科学 | 819篇 |
综合类 | 208篇 |
一般理论 | 3篇 |
预防医学 | 356篇 |
眼科学 | 144篇 |
药学 | 565篇 |
1篇 | |
中国医学 | 42篇 |
肿瘤学 | 427篇 |
出版年
2023年 | 37篇 |
2022年 | 88篇 |
2021年 | 191篇 |
2020年 | 109篇 |
2019年 | 139篇 |
2018年 | 161篇 |
2017年 | 121篇 |
2016年 | 142篇 |
2015年 | 167篇 |
2014年 | 228篇 |
2013年 | 278篇 |
2012年 | 359篇 |
2011年 | 343篇 |
2010年 | 228篇 |
2009年 | 199篇 |
2008年 | 298篇 |
2007年 | 248篇 |
2006年 | 280篇 |
2005年 | 242篇 |
2004年 | 194篇 |
2003年 | 190篇 |
2002年 | 182篇 |
2001年 | 139篇 |
2000年 | 150篇 |
1999年 | 126篇 |
1998年 | 77篇 |
1997年 | 51篇 |
1996年 | 46篇 |
1995年 | 36篇 |
1994年 | 38篇 |
1993年 | 38篇 |
1992年 | 97篇 |
1991年 | 79篇 |
1990年 | 74篇 |
1989年 | 78篇 |
1988年 | 77篇 |
1987年 | 68篇 |
1986年 | 66篇 |
1985年 | 66篇 |
1984年 | 44篇 |
1983年 | 24篇 |
1982年 | 28篇 |
1980年 | 24篇 |
1979年 | 40篇 |
1977年 | 34篇 |
1975年 | 35篇 |
1974年 | 29篇 |
1973年 | 25篇 |
1972年 | 32篇 |
1971年 | 25篇 |
排序方式: 共有6222条查询结果,搜索用时 15 毫秒
91.
An unusual case of colitis 总被引:1,自引:0,他引:1
92.
S. Dasarathy S. C. Misra S. K. Acharya M. Irshad Y. K. Joshi P. Venugopal B. N. Tandon 《Liver international》1992,12(3):116-120
ABSTRACT— We studied the risk of post-transfusion hepatitis (PTH) in recipients of blood collected from voluntary donors screened for HBsAg. Two hundred and fifty patients without any previous history of liver disease or transfusion were followed up for 12 months subsequent to cardiac surgery. Thirty-five of them had closed-heart surgery without receiving transfusion and served as controls. The remaining 215 patients received single-point transfusions (mean 4 ± 2.4 units). None of the controls and 15 (6.9%) blood recipients developed PTH. Three (20%) patients had hepatitis-B-virus-induced hepatitis while the remainder (80%) had non A, non B (NANB) hepatitis. The number of units of blood transfused and surrogate markers for development of PTH (donor alanine aminotransferase, anti-HBc and anti-HBs antibody) were not associated with the occurrence of PTH (p>0.05). Nine (60%) of the 15 patients developing PTH were asymptomatic. All the patients recovered from the PTH, except one who died of fulminant hepatitis. At the end of 1 year of follow-up, none of the patients had evidence of chronic hepatitis. Only three (25%) of the patients with NANB-PTH developed anti-hepatitis C virus (HCV) antibody during the follow-up. We conclude that the incidence of PTH in India is similar to other parts of the world and NANB virus was the major cause of the PTH. The absence of chronicity and lack of seroconversion to anti-HCV antibody in the majority of the patients after 1 year of follow-up may suggest the possibility of a NANB virus other than HCV as the major cause of PTH in India. 相似文献
93.
Ebenezer Oni Oluseye Ogunmoroti Norrina Allen Mouaz H. A-Mallah Ron Blankstein Seth S. Martin Irfan Zeb Mary Cushman Parag H. Joshi Matthew J. Budoff Michael J. Blaha Roger S. Blumenthal Emir Veledar Khurram Nasir 《The American journal of medicine》2021,134(4):519-525
BackgroundThe American Heart Association (AHA) has defined Life's Simple 7 (LS7) as a measure of overall cardiovascular health . Nonalcoholic fatty liver disease (NAFLD) has been involved as a risk factor for cardiovascular disease. We evaluated the association between LS7 and NAFLD.MethodsWe evaluated participants form the Multi-Ethnic Study of Atherosclerosis (MESA) cohort. Cardiovascular health score was calculated from the Life's Simple 7 metrics. A score of 0-8 was considered inadequate, 9-10 average, and 11-14 optimal. NAFLD was defined using noncontrast cardiac computed tomography (CT) and a liver/spleen attenuation ratio (L/S) < 1. Multivariable regression were performed to evaluate the association.ResultsOur cross-sectional analysis of 3901 participants showed 19% (n = 747) had optimal cardiovascular health, 33% (n = 1270) had average, and 48% (n = 1884) had inadequate. White participants were most likely to have an optimal score (51%, n = 378), whereas African American participants had the lowest proportion with optimal scores (16%, n = 120; P < 0.001). The overall prevalence of NAFLD was 18% with a distribution of 7%, 14%, and 25% in the optimal, average, and inadequate score categories, respectively (P < 0.001). Adjusted for risk factors, average and optimal health categories had lower odds of NAFLD compared to those with inadequate scores: odds ratio for average, 0.44 (95% confidence interval 0.36-0.54); optimal, odds ratio 0.19 (95% confidence interval 0.14-0.26). This association was similar across gender, race and age groups.ConclusionA more favorable cardiovascular health score was associated with a lower prevalence of NAFLD. This study may suggest a potential of Life's Simple 7 in the prevention of liver disease. 相似文献
94.
Anil Rana Jimi Marin Alex Monika Chauhan Gaurav Joshi Raj Kumar 《Medicinal chemistry research》2015,24(3):903-920
Past few decades have witnessed the dawn of new diseases in which cancer is a major problem and the race ensued to eradicate cancer by charting out various effective therapeutic regimens. Circumventing resistance issues and combating the toxicity and selectivity problems are matter-of-concern in cancer treatment. Persistent failure to ensure complete remission and eradication of cancer instigated the researchers to exploit the strategies of combining pharmacophores as targeted therapeutic agents. Momentous improvement in the pharmacokinetic as well as pharmacodynamic profile resulting in the enhancement of bioavailability was seen with the introduction of these pharmacophores. The scope of molecular hybridization can be clearly exemplified through the US-FDA approved estramustine and others such as CUDC-101, CBLC-137, PLX3397, E-3810, and CUDC-907 that are currently in different phases of clinical trials. This review seeks to highlight and discuss anti-proliferative activity of some important hybrid, dual, and multi-targeted pharmacophores reported to date along with their designs, structure activity relationships, scope, and limitations. Further, an emphasis has been made to summarize US-FDA approved as well as drugs currently undergoing clinical trials of anticancer drug development. 相似文献
95.
Alkesh Kumar Khurana Vikas Gupta Deepti Joshi Abhishek Goyal Ujjawal Khurana Abhijit Pakhare 《The Indian journal of tuberculosis》2021,68(2):215-220
IntroductionThe variable course of illness in patients of Tubercular lymphadenitis remains a therapeutic challenge to treating physicians in a significant proportion of patients. This study was aimed to explore the possible determinants which could predict the outcome of this subgroup of patients.MethodologyThis was a prospective cohort study where 94 patients of TB lymphadenitis were enrolled who could be followed up till the end of treatment. They were evaluated in the beginning and monitored till the end of treatment keeping into account the clinical behaviour of lymph nodes during the course of Anti tubercular chemotherapy.ResultsOut of 94 patients, 60 had their lymph nodes resolved at the end of prescribed treatment duration wheras 34 were classified as partial responders. Another 26 amongst them had their nodes resolved by an extension of continuation phase by 3–6 months. Presence of bilateral and multiple lymph nodes, necrosis on Fine needle aspiration at initial diagnosis and occurrence of Paradoxical upgrading reaction were associated with the partial resolution of lymph nodes at the end of stipulated ATT duration.ConclusionTreatment duration should be individualized by the treating physicians. Certain parameters mentioned above can be taken as warning signals of patients ending up as partial responders and hence the need of a prolonged extension phase. 相似文献
96.
97.
Balram Bhairavi Joshi Harshad Wong Karen Kroeker Karen I. Dieleman Levinus A. Halloran Brendan P. Baumgart Daniel C. Peerani Farhad 《Digestive diseases and sciences》2021,66(11):3985-3992
Digestive Diseases and Sciences - While there is recent literature to support the discontinuation of 5-aminosalicylate (5-ASA) upon the initiation of biologics, continuing 5-ASA after treatment... 相似文献
98.
Gentle Sunder Shrestha Pankaj Joshi Santosh Chhetri Ragesh Karn Subhash Prasad Acharya 《Indian Journal of Critical Care Medicine》2015,19(5):283-285
Refractory and super-refractory status epilepticus is a life-threatening neurological emergency, associated with high morbidity and mortality. Treatment should be aimed to stop seizure and to avoid cerebral damage and another morbidity. Published data about effectiveness, safety and outcome of various therapies and treatment approaches are sparse and are mainly based on small case series and retrospective data. Here we report successful management of two cases of super-refractory status epilepticus refractory to anesthetic therapy with midazolam and complicated by septic shock, managed successfully with ketamine infusion. 相似文献
99.
Diana Lehmann Kathrin Schubert Pushpa R Joshi Steven A Hardy Helen A L Tuppen Karen Baty Emma L Blakely Christian Bamberg Stephan Zierz Marcus Deschauer Robert W Taylor 《European journal of human genetics : EJHG》2015,23(12):1735-1738
Pathogenic mitochondrial DNA (mtDNA) point mutations are associated with a wide range of clinical phenotypes, often involving multiple organ systems. We report two patients with isolated myopathy owing to novel mt-tRNAAla variants. Muscle biopsy revealed extensive histopathological findings including cytochrome c oxidase (COX)-deficient fibres. Pyrosequencing confirmed mtDNA heteroplasmy for both mutations (m.5631G>A and m.5610G>A) whilst single-muscle fibre segregation studies (revealing statistically significant higher mutation loads in COX-deficient fibres than in COX-positive fibres), hierarchical mutation segregation within patient tissues and decreased steady-state mt-tRNAAla levels all provide compelling evidence of pathogenicity. Interestingly, both patients showed very high-mutation levels in all tissues, inferring that the threshold for impairment of oxidative phosphorylation, as evidenced by COX deficiency, appears to be extremely high for these mt-tRNAAla variants. Previously described mt-tRNAAla mutations are also associated with a pure myopathic phenotype and demonstrate very high mtDNA heteroplasmy thresholds, inferring at least some genotype:phenotype correlation for mutations within this particular mt-tRNA gene. 相似文献
100.
Rameshwar P Joshi DD Yadav P Qian J Gascon P Chang VT Anjaria D Harrison JS Song X 《Blood》2001,97(10):3025-3031
Bone marrow (BM) fibrosis may occur in myeloproliferative diseases, lymphoma, myelodysplastic syndrome, myeloma, and infectious diseases. In this study, the role of substance P (SP), a peptide with pleiotropic functions, was examined. Some of its functions-angiogenesis, fibroblast proliferation, and stimulation of BM progenitors-are amenable to inducing BM fibrosis. Indeed, a significant increase was found in SP-immunoreactivity (SP-IR) in the sera of patients with BM fibrosis (n = 44) compared with the sera of patients with hematologic disorders and no histologic evidence of fibrosis (n = 46) (140 +/-12 vs 18 +/-3; P <.01). Immunoprecipitation of sera SP indicated that this peptide exists in the form of a complex with other molecule(s). It was, therefore, hypothesized that SP might be complexed with NK-1, its natural receptor, or with a molecule homologous to NK-1. To address this, 3 cDNA libraries were screened that were constructed from pooled BM stroma or mononuclear cells with an NK-1 cDNA probe. A partial clone (clone 1) was retrieved that was 97% homologous to the ED-A region of fibronectin (FN). Furthermore, sequence analyses indicated that clone 1 shared significant homology with exon 5 of NK-1. Immunoprecipitation and Western blot analysis indicated co-migration of SP and FN in 27 of 31 patients with BM fibrosis. Computer-assisted molecular modeling suggested that similar secondary structural features between FN and NK-1 and the relative electrostatic charge might explain a complex formed between FN (negative) and SP (positive). This study suggests that SP may be implicated in the pathophysiology of myelofibrosis, though its role would have to be substantiated in future research. (Blood. 2001;97:3025-3031) 相似文献